Novartis has reportedly filed a lawsuit against Takeda in the US. Trade secrets are feared to have been passed on by a former employee.
According to a media report, Novartis has filed a lawsuit in the US against its Japanese rival Takeda Pharmaceutical. The newspaper “Nikki” wrote in an online article published Friday evening (Swiss time) that the Swiss drugmaker wants to determine whether a former employee of Novartis illegally passed on trade secrets.
Novartis asked the Massachusetts Superior Court to issue a subpoena to inspect Takeda’s documents and business records. Takeda confirmed the legal proceedings at Nikkei’s request, the article continued. “We have communicated to Novartis several times that Takeda is actively investigating this matter,” a Takeda spokesperson was quoted as saying.
A spokesperson for Novartis told Nikkei, “The company takes the confidentiality and security of our proprietary information seriously and will take the necessary steps to protect this information from inappropriate disclosure or use.”
According to the complaint, the former Novartis employee transferred about 10,000 internal files to his personal email address a month before he left the company in May. These documents include sales, technical and financial details, the complaint said in the court. The employee then moved to Takeda in July, Novartis said in the complaint.
The Basel pharmaceutical company wants to find out if trade secrets were stolen and if Takeda used the information.